Home › Therapeutic areas › Respiratory › Alpha-1 Antitrypsin Deficiency

Alpha-1 Antitrypsin Deficiency (4 companies)

Companies with an active program in Alpha-1 Antitrypsin Deficiency.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
FDMT 4D Molecular Therapeutics OphthalmologyRespiratory Rare 1 Phase 3 $608M 5
BEAM Beam Therapeutics HematologyMetabolic+1 Rare 1 Phase 2 $2.14B 6
PRME Prime Medicine GI/HepatologyRespiratory Rare 1 Phase 1 $699M 3
WVE Wave Life Sciences MetabolicNeurology+1 Rare 1 Phase 2 $560M 5